ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAllschwilPalto Therapeutics AG
Palto Therapeutics AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Palto Therapeutics AG develops novel formulations for biological drugs, focusing on oligonucleotide-based therapeutics such as siRNAs to enable targeted cellular uptake and cytoplasmic activation. The company designs proprietary formulation and delivery strategies to address in vivo stability and achieve tissue- or cell-type-specific distribution.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.9/5

Palto Therapeutics AG

✓ Offered3
Development of formulations for biological medicines
Development of novel formulations for biological medicines with direct, targeted delivery to diseased cells and tissues; focus on siRNA-based active ingredients and cytoplasmic activation.
Development of oligonucleotide therapeutics
Development of oligonucleotide-based therapeutics such as siRNAs and antisense oligonucleotides for precise, personalized treatments of various life-threatening diseases.
Development of active ingredient delivery strategies
Modification of clinically proven and new delivery strategies with functionalized formulations to stabilize in biological fluids and enable targeted distribution to tissues or cell types.
Trust & reputation

ranQ Trust Score of Palto Therapeutics AG: 3.9 out of 5.0

Trust Score3.9/ 5.0

High

x

Data basis 58% · As of October 2026

Palto Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Palto Therapeutics AG scores 72.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Palto Therapeutics AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Palto Therapeutics AG scores 7.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.5.44%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Palto Therapeutics AG reaches a ranQ Trust Score of 3.9 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

October 30, 2023Media
Palto Therapeutics enhances RNA-based therapeutics
startupticker.ch

Knowledge

No knowledge articles yet

Once Palto Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Palto Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Palto Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Palto Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuweilerstrasse 16
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-423.670.343
Founded
2020 · 6 years
Last commercial register change
December 24, 2020
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AS
    AlphaMol Science AG
    Allschwil
    CT
    CAPTOR THERAPEUTICS GmbH
    Allschwil
    AT
    Alloy Therapeutics (Switzerland) AG
    Allschwil
    IP
    Idorsia Pharmaceuticals Ltd
    Allschwil
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    NB
    Nanolynx Biologics AG
    Allschwil
    BA
    Baliopharm AG
    Reinach Bl
    PP
    Perseo pharma AG
    Muttenz